Molecular and Cellular Biochemistry

, Volume 53, Issue 1–2, pp 129–152 | Cite as

Tyrosine hydroxylase regulation in the central nervous system

  • Joseph M. Masserano
  • Norman Weiner
Article

Summary

Tyrosine hydroxylase is considered to be the rate-limiting enzyme in the synthesis of catecholamines in both the central and peripheral nervous system. Increased or decreased neuronal activity, stress, lesions, drug effects, endocrinological manipulations and experimental models of hypertension are associated with alterations in tyrosine hydroxylase activity in the central nervous system. In many of these instances, the changes in the activity of tyrosine hydroxylase in the central nervous system that occur are localized to discrete catecholaminergic pathways and nuclei in the brain. The purpose of this review is to summarize and assess this information and to provide insight into the function of catecholamine systems in the brain and their interactions with other putative neurotransmitter systems.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weiner, N., 1975. The Basic Neurosciences; The Nervous System (Brady, R. O., ed.), Vol. 1, pp. 341–354, Raven Press, New York.Google Scholar
  2. 2.
    Levitt, M., Spector, S., Sjoerdsma, A. and Udenfriend, S., 1965. J. Pharmacol. Exp. Ther. 148: 1–8.Google Scholar
  3. 3.
    Weiner, N., Lee, F.-L., Dreyer, E. and Barnes, E., 1978. Life Sci. 22: 1197–1216.Google Scholar
  4. 4.
    Morgenroth, V. H., III, Boadle-Biber, M. and Roth, R. H., 1974. Proc. Natl. Acad. Sci. 71: 4283–4287.Google Scholar
  5. 5.
    Roth, R. H., Morgenroth, V. H., III and Salzman, P. M., 1975. Naunyn-Schmiedeberg's Arch. Pharmacol. 289: 327–343.Google Scholar
  6. 6.
    Masserano, J. M. and Weiner, N., 1979. Mol. Pharmacol. 16: 513–528.Google Scholar
  7. 7.
    Masserano, J. M. and Weiner, N., 1981. Life Sci. 29: 2025–2029.Google Scholar
  8. 8.
    Masserano, J. M. and Weiner, N., 1981. Regulation and Function of Monoamine Enzymes (Usdin, E., Weiner, N. and Youdim, M. B. H., eds.), pp. 75–81, Macmillan, London.Google Scholar
  9. 9.
    Zivkovic, B., Guidotti, A. and Costa, E., 1974. Mol. Pharmacol. 10: 727–735.Google Scholar
  10. 10.
    Lovenberg, W. and Bruckwick, E. A., 1975. Psychopharmacol. Bull. 11: 11–12.Google Scholar
  11. 11.
    Lovenberg, W., Bruckwick, E. A. and Hanbauer, I., 1975. Proc. Natl. Acad. Sci. 72: 2955–2958.Google Scholar
  12. 12.
    Andrews, D. W., Langan, T. A. and Weiner, N., 1983. Proc. Natl. Acad. Sci. U.S.A., in press.Google Scholar
  13. 13.
    Kuczenski, R. T. and Mandell, A. J., 1972. J. Neurochem. 19: 131–137.Google Scholar
  14. 14.
    Lloyd, T. and Kaufman, S., 1974. Biochem. Biophys. Res. Comm. 59: 1261–1269.Google Scholar
  15. 15.
    Raese, J. R., Patrick, L. and Barchas, J. D., 1976. Biochem. Pharmacol. 25: 2245–2250.Google Scholar
  16. 16.
    Katz, I. R., Yamauchi, T. and Kaufman, S., 1976. Biochim. Biophys. Acta 429: 84–95.Google Scholar
  17. 17.
    Nagatsu, T., Numata, Y., Kato, T., Sugiyama, K. and Akino, M., 1978. Biochim. Biophys. Acta 523: 47–52.Google Scholar
  18. 18.
    Kurosawa, A., Guidotti, A., and Costa, E., 1979. Mol. Pharmacol. 15: 115–130.Google Scholar
  19. 19.
    Kurosawa, A., Guidotti, A. and Costa, E., 1976. Science 193: 691–693.Google Scholar
  20. 20.
    Weiner, N., 1979. Aromatic Amino Acid Hydroxylases and Mental Disease (Youdim, M. B. H., ed.), pp. 141–190, John Wiley and Sons Ltd.Google Scholar
  21. 21.
    Weiner, N., 1970. Ann. Rev. Pharmacol. 10: 273–290.Google Scholar
  22. 22.
    Mandell, A. J., 1978. Ann. Rev. Pharmacol. Toxicol. 18: 461–493.Google Scholar
  23. 23.
    Falck, B., Hillarp, N. A., Thieme, G. and Thorp, A., 1962. J. Histochem. Cytochem. 10: 348–354.Google Scholar
  24. 24.
    Dahlstrom, A. and Fuxe, K., 1964. Acta Physiol. Scand. 62, Suppl. 232: 1–55.Google Scholar
  25. 25.
    Ungerstedt, U., 1971. Acta Physiol. Scand. Suppl. 367: 1–48.Google Scholar
  26. 26.
    Livett, B. G., 1973. Br. Med. Bull. 29: 93–99.Google Scholar
  27. 27.
    Kobayashi, R. R. M., Palkovits, M., Kopin, I. J. and Jacobowitz, D. M., 1974. Brain Research 77: 269–279.Google Scholar
  28. 28.
    Zigmond, R. E. and Ben-Ari, Y., 1977. Proc. Natl. Acad. Sci. U.S.A. 74: 3078–3080.Google Scholar
  29. 29.
    Roth, R. H., Salzman, P. M. and Morgenroth, V. H., III, 1974. Biochem. Pharmacol. 23: 2779–2784.Google Scholar
  30. 30.
    Salzman, P. M. and Roth, R. H., 1980. J. Pharmacol. Exp. Ther. 212: 64–73.Google Scholar
  31. 31.
    Murrin, C., Morgenroth, V. H., III and Roth, R. H., 1976. Mol. Pharmacol. 12: 1070–1081.Google Scholar
  32. 32.
    Schlehuber, C. J., Segal, D. S. and Spooner, C. E., 1975. Brain Research 91: 341–347.Google Scholar
  33. 33.
    Walters, J. R., Aghajanian, G. K. and Roth, R. H., 1972. Proceedings of the Fifth International Congress on Pharmacology, Abstract 1472, p. 246.Google Scholar
  34. 34.
    Walters, J. R. and Roth, R. H., 1974. J. Pharmacol. Exp. Ther. 191: 82–91.Google Scholar
  35. 35.
    Tarda, C., 1975. Pharmac. Biochem. Behav. 3: 735–738.Google Scholar
  36. 36.
    Farjo, I. B. and Blackwood, D. H. R., 1978. Brain Research 153: 423–426.Google Scholar
  37. 37.
    Ross, R. A., Tong, H. J. and Reis, D. J., 1975. Brain Research 92: 57–72.Google Scholar
  38. 38.
    Buda, M., Roussel, B., Renaud, B. and Pujol, J.-F., 1975. Brain Research 93: 564–569.Google Scholar
  39. 39.
    Morgenroth, V. H., III, Walters, J. R. and Roth, R. H., 1976. Biochem. Pharmacol. 25: 655–661.Google Scholar
  40. 40.
    Reis, D. J., Gilad, G., Pickel, V. M. and Joh, T. H., 1978. Brain Research 144: 325–342.Google Scholar
  41. 41.
    Gilad, G. and Reis, D. J., 1978. Brain Research 149: 141–153.Google Scholar
  42. 42.
    Ross, R. A. and Reis, D. J., 1981. Exp. Neurol. 73: 571–575.Google Scholar
  43. 43.
    Bloom, F. E., Algeri, S.; Groppetti, A., Revuelta, A. and Costa, E., 1969. Science 166: 1284–1286.Google Scholar
  44. 44.
    Uretsky, N. J. and Iversen, L. L., 1970. J. Neurochem. 17: 269–278.Google Scholar
  45. 45.
    Breese, G. R. and Taylor, T. D., 1970. J. Pharmacol. Exp. Ther. 174: 413–420.Google Scholar
  46. 46.
    Acheson, A. L., Zigmond, M. J. and Stricker, E. M., 1980. Science 207: 537–540.Google Scholar
  47. 47.
    Acheson, A. L. and Zigmond, M. J., 1981. J. Neuroscience 1: 493–504.Google Scholar
  48. 48.
    Thoenen, H., 1970. Nature 228: 861–862.Google Scholar
  49. 49.
    Chuang, D., Zsilla, G. and Costa, E., 1975. Mol. Pharmacol. 11: 784–794.Google Scholar
  50. 50.
    Kvetnansky, R., Weise, V. K. and Kopin, I. J., 1970. Endocrinology 87: 744–749.Google Scholar
  51. 51.
    Masserano, J. M., Takimoto, G. S. and Weiner, N., 1981. Science 214: 662–665.Google Scholar
  52. 52.
    Gilad, G. M. and McCarty, R., 1981. Brain Research 206: 239–243.Google Scholar
  53. 53.
    Palkovits, M., Kobayashi, R. M., Kizer, J. S., Jacobowitz, D. M. and Kopin, I. J., 1975. Neuroendocrinology 18: 144–153.Google Scholar
  54. 54.
    Lamprecht, F., Eichelman, B., Thoa, N. B., Williams, R. B. and Kopin, I. J., 1972. Science 177: 1214–1215.Google Scholar
  55. 55.
    Zigmond, R. E., Schorr, F. and Iversen, L. L., 1974. Brain Research 70: 547–552.Google Scholar
  56. 56.
    Tissar, A. H., Argiolas, A., Fadda, F., Serra, G. and Gessa, G. L., 1979. Naunyn-Schmiedeberg's Arch. Pharmacol. 308: 155–157.Google Scholar
  57. 57.
    Stone, E. A., Freedman, L. S. and Margano, L. E., 1978. Pharmacol. Biochem. Behav. 9: 551–553.Google Scholar
  58. 58.
    Weiss, J. M., Glazer, H. I., Pohorecky, L. A., Brick, J. and Miller, N. E., 1975. Psychomatic Med. 37: 522–534.Google Scholar
  59. 59.
    Raab, A. and Oswald, R., 1980. Physiol. Behav. 24: 387–394.Google Scholar
  60. 60.
    Musacchio, J. M., Julou, L., Kety, S. S. and Glowinski, J., 1969. Proc. Natl. Acad. Sci. 63: 1117–1119.Google Scholar
  61. 61.
    Tiplady, B., Killian, J. J. and Mandel, P., 1976. Life Sci. 18: 1065–1070.Google Scholar
  62. 62.
    Boarder, M. R., Feldon, J., Gray, J. A. and Filleny, M., 1979. Neurosci. Letters 15: 211–215.Google Scholar
  63. 63.
    Zivkovic, B. and Guidotti, A., 1974. Brain Research 79: 505–509.Google Scholar
  64. 64.
    Zivkovic, B., Guidotti, A., Revuelta, A. and Costa, E., 1975. J. Pharmacol. Exp. Ther. 194: 37–46.Google Scholar
  65. 65.
    Zivkovic, B., Guidotti, A. and Costa, E., 1975. Chemical Tools in Catecholamine Research (Almgren, O., Carlsson, A. and Engel, J., eds.), Vol. II, pp. 45–52, North-Holland Publishing Co., Amsterdam.Google Scholar
  66. 66.
    Guidotti, A., 1980. Adv. Biochem. Psychopharmacol. 24: 1–8.Google Scholar
  67. 67.
    Zivkovic, B., Guidotti, A. and Costa, E., 1975. J. Pharm. Pharmac. 27: 359–360.Google Scholar
  68. 68.
    Stoff, D. M. and Gale, K., 1981. Brain Research 211: 492–496.Google Scholar
  69. 69.
    Bunney, B. S., Walters, J. R., Roth, R. H. and Aghajanian, G. K., 1973. J. Pharmacol. Exp. Ther. 185: 560–571.Google Scholar
  70. 70.
    Aghajanian, G. K. and Bunney, B. S., 1977. Naunyn-Schmiedeberg's Arch. Pharmacol. 297: 1–7.Google Scholar
  71. 71.
    Roth, R. H., 1973. Nature 245: 123–125.Google Scholar
  72. 72.
    Zivkovic, B., Guidotti, A. and Costa, E., 1975. Naunyn-Schmiedeberg's Arch. Pharmacol. 291: 193–200.Google Scholar
  73. 73.
    Bjorklund, A. and Lindvall, O., 1975. Brain Research 83: 531–537.Google Scholar
  74. 74.
    Korf, J., Zieleman, M. and Westernik, B. H. C., 1976. Nature 260: 257–258.Google Scholar
  75. 75.
    Tissari, H. A., Porceddu, M. L., Argiolas, A., DiChiara, G. and Gessa, G. L., 1978. Life Sci. 23: 653–658.Google Scholar
  76. 76.
    McGeer, E. G., Innane, V. T. and McGeer, P. L., 1976. Brain Research 118: 356–358.Google Scholar
  77. 77.
    Schwarz, R. and Coyle, J. T., 1977. Brain Research 127: 235–249.Google Scholar
  78. 78.
    Waggoner, W. G., McDermed, J. and Leighton, H. J., 1980. Mol. Pharmacol. 18: 91–99.Google Scholar
  79. 79.
    Quik, M., Emson, P. C. and Joyce, E., 1979. Brain Research 167: 355–365.Google Scholar
  80. 80.
    Gale, K. N. and Guidotti, A., 1976. Nature 263: 691–693.Google Scholar
  81. 81.
    Guidotti, A. and Gale, K., 1977. Adv. Biochem. Psychopharmacol. 16: 455–460.Google Scholar
  82. 82.
    Fonnum, F., Grofova, I., Rinvik, E., Storm-Mathesen, J. and Walberg, F., 1974. Brain Research 71: 71–92.Google Scholar
  83. 83.
    Gale, K., Howg, J.-S. and Guidotti, A., 1977. Brain Research 136: 371–375.Google Scholar
  84. 84.
    Precht, W. and Yoshida, M., 1971. Brain Research 32: 229–233.Google Scholar
  85. 85.
    Gale, K. and Casu, M., 1981. Mol. Cell. Biochem. 39: 369–405.Google Scholar
  86. 86.
    Gale, K., Costa, E., Toffano, G., Howg, J.-S. and Guidotti, A., 1978. J. Pharmacol. Exp. Ther. 206: 29–37.Google Scholar
  87. 87.
    Hong, J. S., Yang, H.-Y. T., Racagni, G. and Costa, E., 1977. Brain Research 122: 541–544.Google Scholar
  88. 88.
    Walker, R. V., Kemp, J. A., Yajima, H., Kitagawa, K. and Woodruff, G. N., 1976. Experientia 32: 214–215.Google Scholar
  89. 89.
    Casu, M. and Gale, K., 1981. J. Pharmacol. Exp. Ther. 217: 177–180.Google Scholar
  90. 90.
    Lerner, P., Nose, P., Gordon, E. K. and Lovenberg, W., 1977. Science 197: 181–183.Google Scholar
  91. 91.
    Lovenberg, W., Alphs, L., Pradshan, S., Bruckwick, E. and Levine, R., 1980. Adv. Biochem. Psychopharmacol. 24: 9–15.Google Scholar
  92. 92.
    Pradhan, S., Alphs, L. and Lovenberg, W., 1981. Neuropharmacol. 20: 149–154.Google Scholar
  93. 93.
    Guidotti, A., Gale, K., Toffano, G. and Vargas, F. M., 1978. Life Sci. 23: 501–506.Google Scholar
  94. 94.
    Gale, K., 1980. Adv. Biochem. Psychopharmacol. 24: 23–29.Google Scholar
  95. 95.
    Tissari, A. H., Casu, M. and Gessa, G. L., 1979. Life Sci. 24: 411–416.Google Scholar
  96. 96.
    Bacopoulos, N. G., Bustos, G., Redmond, D. E., Banlu, J. and Roth, R. H., 1978. Brain Research 157: 396–401.Google Scholar
  97. 97.
    Bacopoulos, N. G., Bustos, G., Redmond, D. E. and Roth, R. H., 1982. J. Pharmacol. Exp. Ther. 221: 22–28.Google Scholar
  98. 98.
    Weiner, N., 1980. The Pharmacological Basis of Therapeutics (Goodman, L. S. and Gilman, A., eds.) p. 202, Macmillan Publishing Col., Inc., New York.Google Scholar
  99. 99.
    Mueller, R. A., Thoenen, H, and Axelrod, J., 1969. J. Pharmacol. Exp. Ther. 169: 74–79.Google Scholar
  100. 100.
    Segal, D. S., Sullivan, J. L., III, Kuczenski, R. T. and Mandell, A., 1971. Science 27: 847–849.Google Scholar
  101. 101.
    Reis, D. J., Job, T. H., Ross, R. A. and Pickel, V. M., 1974. Brain Research 81: 380–386.Google Scholar
  102. 102.
    Reis, D. J., Job, T. H. and Ross, R. A., 1975. J. Pharmacol. Exp. Ther. 193: 775–784.Google Scholar
  103. 103.
    Black, I. B., 1975. Brain Research 95: 170–176.Google Scholar
  104. 104.
    Zigmond, R. E., 1979. J. Neurochem. 32: 23–29.Google Scholar
  105. 105.
    Sorimachi, M., 1975. Brain Research 99: 400–404.Google Scholar
  106. 106.
    Renaud, B., Job, T. H., Snyder, D. W. and Reis, D. J., 1979. Brain Research 176: 169–174.Google Scholar
  107. 107.
    Carr, L. A. and Moore, K. E., 1969. Science 164: 322–323.Google Scholar
  108. 108.
    Fibiger, H. C. and McGeer, E. G., 1971. Eur. J. Pharmacol. 16: 176–180.Google Scholar
  109. 109.
    Mandell, A. J., Knapp, S., Kuczenski, R. T. and Segal, D. S., 1972. Biochem. Pharmacol. 21: 2737–2750.Google Scholar
  110. 110.
    Hulme, E. C., Hill, R., North, M. and Kibby, M. R., 1974. Biochem. Pharmacol. 23: 1393–1404.Google Scholar
  111. 111.
    Kogan, F. J., Nichols, W. K. and Gibb, J. W., 1976. Eur. J. Pharmacol. 36: 363–371.Google Scholar
  112. 112.
    Koda, L. Y. and Gibb, J. W., 1973. J. Pharmacol. Exp. Ther. 185: 42–48.Google Scholar
  113. 113.
    Buening, M. K. and Gibb, J. W., 1974. Eur. J. Pharmacol. 26: 30–34.Google Scholar
  114. 114.
    Bakhit, C., Kwok, Y. C. and Gibb, J. W., 1980. Life Sci. 26: 1815–1819.Google Scholar
  115. 115.
    Gibb, J. W. and Kugan, F. J., 1979. Naunyn-Schmiedeberg's Arch. Pharmacol. 310: 185–187.Google Scholar
  116. 116.
    Hotchkiss, A. J., Morgan, M. E. and Gibb, J. W., 1979. Life Sci. 25: 1373–1378.Google Scholar
  117. 117.
    Hotchkiss, A. J. and Gibb, J. W., 1980. J. Pharmacol. Exp. Ther. 214: 257–262.Google Scholar
  118. 118.
    Bardsley, M. E. and Bachelard, H. S., 1981. Biochem. Pharmacol. 30: 1543–1549.Google Scholar
  119. 119.
    Ellison, G., Eison, M. S., Huberman, H. S. and Daniel, F., 1978. Science 201: 276–278.Google Scholar
  120. 120.
    Ulus, I. H. and Wurtman, R. J., 1976. Science 194: 1060–1061.Google Scholar
  121. 121.
    Richardson, J. S., Lamprecht, F., Kazic, T. and Kopin, I. J., 1976. Can. J. Physiol. Pharmacol. 54: 774–778.Google Scholar
  122. 122.
    Lewander, T., Job, T. H. and Reis, D. J., 1975. Nature 258: 440–441.Google Scholar
  123. 123.
    Lewander, T., Joh, T. H. and Reis, D. J., 1977. J. Pharmacol. Exp. Ther. 200: 523–534.Google Scholar
  124. 124.
    Renaud, B., Job, T. H., Snyder, D. W. and Reis, D. J., 1979. Brain Research 176: 169–174.Google Scholar
  125. 125.
    Sullivan, J. L., Segal, D. S., Kuczenski, R. T. and Mandell, A. J., 1972. Biological Psychiatry 4: 193–203.Google Scholar
  126. 126.
    Peters, D. A. V. and Mazurkiewicz-Kwilecki, 1975. J. Pharm. Pharmacol. 27: 671–676.Google Scholar
  127. 127.
    Hockfelt, B., Hedeland, H. and Dymling, J.-F., 1970. Eur. J. Pharmacol. 10: 389–397.Google Scholar
  128. 128.
    Geyskes, G. G., Boen, P. and Dorhount Mess, E. J., 1979. Br. J. Clin. Pharmacol. 7: 55–62.Google Scholar
  129. 129.
    Dix, R. K. and Johnson, E. M., 1977. Eur. J. Pharmacol. 44: 153–159.Google Scholar
  130. 130.
    Kane, W. H. and Johnson, E. M., 1978. Eur. J. Pharmacol. 51: 309–312.Google Scholar
  131. 131.
    DiStefano, P., Fox, G. and Johnson, E. M., 1980. J. Pharmacol. Exp. Ther. 214: 263–268.Google Scholar
  132. 132.
    Gysling, K. and Roth, R. H., 1981. Function and Regulation of Monoamine Enzymes: Basic and Clinical Aspects (Usdin, E., Weiner, N. and Youdim, M., eds.) Macmillan Pub. Ltd., London.Google Scholar
  133. 133.
    French, T. A., Masserano, J. M. and Weiner, N., 1983. J. Pharm. Pharmacol., in press.Google Scholar
  134. 134.
    Smith, R. C., Taylor, D., Ho, B. T. and Leelavathi, D. E., 1980. J. Neural Transmission 48: 289–295.Google Scholar
  135. 135.
    Ho, B. T., Taylor, D. and Englert, L. F., 1973. Res. Comm. Chem. Pathol. Pharmacol. 5: 851–854.Google Scholar
  136. 136.
    Peters, D. A. V. and Tang, S., 1977. J. Neurochem. 28: 59–62.Google Scholar
  137. 137.
    Cicero, T. J., Wilcox, C. E., Smithloff, B. R., Meyer, E. R. and Sharpe, L. G., 1973. Biochem. Pharmacol. 22: 3237–3246.Google Scholar
  138. 138.
    Branchey, L., Bodner, S. and Friedhoff, A. J., 1974. Res. Comm. Chem. Pathol. Pharmacol. 8: 707–710.Google Scholar
  139. 139.
    Bonnet, K. A., Branchey, L. B., Friedhoff, A. J. and Ehrlich, Y. H., 1978. Life Sci. 22: 2003–2008.Google Scholar
  140. 140.
    Reis, D. J., Hess, P. and Azrnitia, E. C., 1970. Brain Research 20: 309–312.Google Scholar
  141. 141.
    Branchey, L. and Friedhoff, A. J., 1973. Psychopharmacologia 32: 151–156.Google Scholar
  142. 142.
    Detering, W., Edwards, E. Ozand, P. and Karahasan, A., 1980. J. Neurochem. 34: 297–304.Google Scholar
  143. 143.
    Baizer, L., Masserano, J. M. and Weiner, N., 1981. Pharmacol. Biochem. Behav. 15: 945–949.Google Scholar
  144. 144.
    Masserano, J. M., Takimoto, G. S. and Weiner, N., 1983. Exp. Clin. Res., in press.Google Scholar
  145. 145.
    Leger, L. and Descarries, L., 1978. Brain Research 145: 1–13.Google Scholar
  146. 146.
    Pickel, V., Joh, T. H. and Reis, D. J., 1977. Brain Research 131: 197–214.Google Scholar
  147. 147.
    Renaud, B., Buda, M., Lewis, B. D. and Pujol, J-F., 1975. Biochem. Pharmacol. 24: 1739–1742.Google Scholar
  148. 148.
    McRae-Degueurce, A. and Pujol, J-F., 1979. Eur. J. Pharmacol. 59: 131–135.Google Scholar
  149. 149.
    Keane, P. E., Degueurce, A., Renaud, B., Crespi, F. and Pujol, J. F., 1978. Neurosci. Letters 8: 151–158.Google Scholar
  150. 150.
    Crespi, F., Buda, M., McRae-Degueurce, A. and Pujol, J-F., 1980. Brain Research 191: 501–509.Google Scholar
  151. 151.
    Lewis, B. D., Renaud, B., Buda, M. and Pujol, J.-F., 1976. Brain Research 108: 339–340.Google Scholar
  152. 152.
    McRae-Degueurce, A., Berod, A., Mermet, A., Keller, A., Chouvet, G., Joh, T. H. and Pujol, J.-F., 1982. Brain Research 235: 285–301.Google Scholar
  153. 153.
    Werblin, F. S. and Dowling, J. E., 1969. J. Neurophysiol. 32: 339–355.Google Scholar
  154. 154.
    Kramer, S. G., 1971. Invest. Opthol. 10: 438–452.Google Scholar
  155. 155.
    Iuvone, P. M., Galli, C. L., Garrison-Fund, C. K. and Neff, N. H., 1978. Science 202: 901–902.Google Scholar
  156. 156.
    Marshburn, P. B. and Iuvone, P. M., 1981. Brain Research 217: 335–347.Google Scholar
  157. 157.
    Iuvone, P. M., Galli, C. L. and Neff, N. H., 1978. Mol. Pharmacol. 14: 1212–1219.Google Scholar
  158. 158.
    Iuvone, P. M., Job, T. H. and Neff, N. H., 1979. Brain Research 178: 191–195.Google Scholar
  159. 159.
    Cohen, J., Iuvone, P. M. and Neff, N. H., 1981. J. Pharmacol. Exp. Ther. 218: 390–394.Google Scholar
  160. 160.
    Cohen, J. and Neff, N. H., 1982. J. Pharmacol. Exp. Ther. 221: 326–328.Google Scholar
  161. 161.
    Kalra, S. P. and McCann, S. M., 1973. Endocrinology 93: 356–362.Google Scholar
  162. 162.
    Kordon, C. and Glowinski, J., 1972. Neuropharmacology 11: 153–162.Google Scholar
  163. 163.
    Dickerman, S., Clark, J., Dukerman, E. and Meites, J., 1972. Neuroendocrinology 9: 332–340.Google Scholar
  164. 164.
    Maickel, R. P., Westermann, E. O. and Brodie, B. B., 1961. J. Pharmacol. Exp. Ther. 134: 167–175.Google Scholar
  165. 165.
    Kizer, J. S., Palkovits, M., Zivin, J., Brownstein, M., Saavedra, J. M. and Kopin, I. J., 1974. Endocrinology 95: 799–812.Google Scholar
  166. 166.
    Dunn, A. J., Gildersleeve, N. B. and Gray, A. E., 1978. J. Neurochem. 31: 977–982.Google Scholar
  167. 167.
    Rastogi, R. B. and Singhal, R. L., 1974. Brain Research 81: 243–266.Google Scholar
  168. 168.
    Nakahara, T., Uchimura, H., Hirano, M., Saito, M., Kim, J. S. and Matsumoto, T., 1979. Brain Research 179: 396–400.Google Scholar
  169. 169.
    Kizer, J. S., Muth, E. and Jacobowitz, D. M., 1976. Endocrinology 98: 886–893.Google Scholar
  170. 170.
    Nakahara, T., Uchimura, H., Hirano, M., Saito, M. and Ito, M., 1976. Brain Research 117: 351–356.Google Scholar
  171. 171.
    Beattie, C. W. and Martin, M. M., 1976. Experientia 15: 1076–1077.Google Scholar
  172. 172.
    Beattie, C. W., Rodgers, C. H. and Soyka, L. F., 1972. Endocrinology 91: 276–279.Google Scholar
  173. 173.
    Beattie, C. W. and Soyka, L. F., 1973. Endocrinology 93: 1443–1455.Google Scholar
  174. 174.
    Luine, V. N., McEwen, B. S. and Black, I. B., 1977. Brain Research 120: 188–192.Google Scholar
  175. 175.
    Lloyd, T. and Weisz, J., 1978. J. Biol. Chem. 253: 4841–4843.Google Scholar
  176. 176.
    Lloyd, T. and Ebersole, B. J., 1980. J. Neurochem. 34: 726–731.Google Scholar
  177. 177.
    Carr, L. A. and Voogt, J. L., 1980. Brain Research 196: 437–445.Google Scholar
  178. 178.
    Voogt, J. L. and Carr, L. A., 1981. Proc. Soc. Exp. Biol. Med. 166: 277–281.Google Scholar
  179. 179.
    Tobias, H., Carr, L. A. and Voogt, J. L., 1981. Life Sci. 29: 711–716.Google Scholar
  180. 180.
    Ben-Ishay, D., Saliternik, R. and Welner, A., 1972. Experientia 28: 1321–1322.Google Scholar
  181. 181.
    Feuerstein, G., Zamir, N., Ben-Ishay, D. and Gutman, Y., 1979. J. Neurochem. 33: 393–395.Google Scholar
  182. 182.
    Saavedra, J. J., Grabecker, H. and Axelrod, J., 1978. Circulat. Res. 42: 529–534.Google Scholar
  183. 183.
    Versteeg, D. H. G., Dalkovits, M., Van der Gugten, J., Wijnen, H. L. J. M., Smeets, G. W. M. and De Jong, W., 1973. Brain Research 61: 235–252.Google Scholar
  184. 184.
    Nagatsu, T., Ikuta, K., Numata, Y., Kato, T. and Sano, M., 1976. Science 191: 290–291.Google Scholar
  185. 185.
    Nagatsu, T., Kato, T., Numata, Y., Ikuta, K., Sane, M., Nagatsu, I., Umezawa, H., Matsuzaki, M. and Takeuchi, T., 1977. Japan J. Pharmacol. 27: 531–535.Google Scholar
  186. 186.
    Renaud, B., Job, T. H. and Reis, D. J., 1969. Brain Research 173: 164–167.Google Scholar
  187. 187.
    Nagaoka, A. and Lovenberg, W., 1977. Eur. J. Pharmacol. 43: 297–306.Google Scholar
  188. 188.
    Rylett, P., Dean, H. G. and Lee, M. R., 1976. J. Pharm. Pharmacol. 28: 559–562.Google Scholar
  189. 189.
    Jackson, N., Gulliver, P. A. and Dean, H. G., 1981. J. Pharm. Pharmacol. 33: 445–450.Google Scholar
  190. 190.
    Petty, M. A. and Reid, J. L., 1978. Clin. Sci. Mol. Med. 55: 1015–1035.Google Scholar
  191. 191.
    Petty, M. A. and Reid, J. L., 1979. Brain Research 163: 277–288.Google Scholar

Copyright information

© Martinus Nijhoff Publishers 1983

Authors and Affiliations

  • Joseph M. Masserano
    • 1
  • Norman Weiner
    • 1
  1. 1.Department of PharmacologyUniversity of Colorado Health Sciences Center, School of MedicineDenverUSA

Personalised recommendations